Original Source(s)
Biologics Commonly Used in Cutaneous Crohn Disease
-
by Andrea Surnit
May 27, 2026
Related Content
Combination Therapy Shows Potential in Psoriasis, Obesity
Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.
May 20, 2026
-
5 min
Ivarmacitinib Eased Refractory PCA: Case Report
Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.
May 20, 2026
-
4 min
Pediatric Dermatology Clinic now accepting referrals for complex cases
This program provides subspecialty expertise in the diagnosis and management of complex pediatric dermatologic diseases.
